Marshall Anderson - Publications

Affiliations: 
University of Cincinnati, Cincinnati, OH 
Area:
Toxicology, Molecular Biology, Oncology

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Musolf AM, Simpson CL, Moiz BA, Pikielny CW, Middlebrooks CD, Mandal D, de Andrade M, Cole MD, Gaba C, Yang P, You M, Li Y, Kupert EY, Anderson MW, Schwartz AG, et al. Genetic variation and recurrent haplotypes on chromosome 6q23-25 risk locus in familial lung cancer. Cancer Research. PMID 33853833 DOI: 10.1158/0008-5472.CAN-20-3196  0.3
2019 Musolf AM, Moiz BA, Sun H, Pikielny CW, Bossé Y, Mandal D, de Andrade M, Gaba C, Yang P, Li Y, You M, Govindan R, Wilson RK, Kupert EY, Anderson MW, et al. Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p and 4q. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31826912 DOI: 10.1158/1055-9965.Epi-19-0887  0.33
2018 Liu Y, Lusk CM, Cho MH, Silverman EK, Qiao D, Zhang R, Scheurer ME, Kheradmand F, Wheeler DA, Tsavachidis S, Armstrong G, Zhu D, Wistuba II, Chow CB, Behrens C, ... ... Anderson M, et al. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29981437 DOI: 10.1016/J.Jtho.2018.06.016  0.339
2018 Byun J, Schwartz AG, Lusk C, Wenzlaff AS, de Andrade M, Mandal D, Gaba C, Yang P, You M, Kupert EY, Anderson MW, Han Y, Li Y, Qian D, Stilp A, et al. Genome-Wide Association Study of Familial Lung Cancer. Carcinogenesis. PMID 29924316 DOI: 10.1093/Carcin/Bgy080  0.369
2017 Musolf AM, Simpson CL, de Andrade M, Mandal D, Gaba C, Yang P, Li Y, You M, Kupert EY, Anderson MW, Schwartz AG, Pinney SM, Amos CI, Bailey-Wilson JE. Parametric Linkage Analysis Identifies Five Novel Genome-Wide Significant Loci for Familial Lung Cancer. Human Heredity. 82: 64-74. PMID 28817824 DOI: 10.1159/000479028  0.357
2017 Musolf AM, Simpson CL, de Andrade M, Mandal D, Gaba C, Yang P, Li Y, You M, Kupert EY, Anderson MW, Schwartz AG, Pinney SM, Amos CI, Bailey-Wilson JE. Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies. Genes. 8. PMID 28106732 DOI: 10.3390/Genes8010036  0.371
2015 Xiong D, Wang Y, Kupert E, Simpson C, Pinney SM, Gaba CR, Mandal D, Schwartz AG, Yang P, de Andrade M, Pikielny C, Byun J, Li Y, Stambolian D, Spitz MR, ... ... Anderson M, et al. A recurrent mutation in PARK2 is associated with familial lung cancer. American Journal of Human Genetics. 96: 301-8. PMID 25640678 DOI: 10.1016/J.Ajhg.2014.12.016  0.369
2014 Karim NA, Bui H, Pathrose P, Starnes S, Patil N, Shehata M, Mostafa A, Rao M, Zarzour A, Anderson M. The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer. Clinical Medicine Insights. Oncology. 8: 139-44. PMID 25520568 DOI: 10.4137/CMO.S18369  0.358
2012 Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, Hua X, Ding F, Lu Y, James M, Ebben JD, Xu H, Adjei AA, Head K, Andrae JW, ... ... Anderson M, et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. 33: 1270-6. PMID 22510280 DOI: 10.1093/Carcin/Bgs148  0.413
2012 Starnes SL, Pathrose P, Wang J, Succop P, Morris JC, Bridges J, Kupert EY, Anderson M. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer. The Annals of Thoracic Surgery. 93: 1606-12. PMID 22440368 DOI: 10.1016/J.Athoracsur.2012.01.048  0.371
2011 Kupert E, Anderson M, Liu Y, Succop P, Levin L, Wang J, Wikenheiser-brokamp K, Chen P, Pinney SM, Macdonald T, Dong Z, Starnes S, Lu S. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules. Bmc Cancer. 11: 513. PMID 22151235 DOI: 10.1186/1471-2407-11-513  0.392
2010 Tichelaar JW, Yan Y, Tan Q, Wang Y, Estensen RD, Young MR, Colburn NH, Yin H, Goodin C, Anderson MW, You M. A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice. Cancer Prevention Research (Philadelphia, Pa.). 3: 1148-56. PMID 20716630 DOI: 10.1158/1940-6207.Capr-10-0023  0.404
2010 Liu P, Yang P, Wu X, Vikis HG, Lu Y, Wang Y, Schwartz AG, Pinney SM, de Andrade M, Gazdar A, Gaba C, Mandal D, Lee J, Kupert E, Seminara D, ... ... Anderson MW, et al. A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Research. 70: 3128-35. PMID 20395203 DOI: 10.1158/0008-5472.Can-09-3583  0.311
2010 Liu P, Vikis HG, Lu Y, Wang Y, Schwartz AG, Pinney SM, Yang P, de Andrade M, Gazdar A, Gaba C, Mandal D, Lee J, Kupert E, Seminara D, Minna J, ... ... Anderson MW, et al. Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 517-24. PMID 20142248 DOI: 10.1158/1055-9965.Epi-09-0791  0.329
2009 Liu Y, Liu P, Wen W, James MA, Wang Y, Bailey-Wilson JE, Amos CI, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Schwartz AG, Gazdar A, ... ... Anderson MW, et al. Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Research. 69: 7844-50. PMID 19789337 DOI: 10.1158/0008-5472.Can-09-1833  0.4
2008 Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Gazdar A, Gaba C, Rothschild H, ... ... Anderson MW, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. Journal of the National Cancer Institute. 100: 1326-30. PMID 18780872 DOI: 10.1093/Jnci/Djn268  0.345
2008 Anderson MW, Goodin C, Zhang Y, Kim S, Estensen RD, Wiedmann TS, Sekar P, Buncher CR, Khoury JC, Garbow JR, You M, Tichelaar JW. Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice. Carcinogenesis. 29: 1594-600. PMID 18515278 DOI: 10.1093/Carcin/Bgn129  0.376
2008 Karim NFA, Bui H, Anderson M, Patil N, Pathrose P, Osman N, Rao MB, Mehta A. Prognostic Correlation Between Neutrophilic Leukocytosis, VEGF, VEGFR and ERCC1 in Advanced Non-Small Cell Lung Cancer (NSCLC) Blood. 112: 4637-4637. DOI: 10.1182/Blood.V112.11.4637.4637  0.334
2007 Vikis H, Sato M, James M, Wang D, Wang Y, Wang M, Jia D, Liu Y, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, ... ... Anderson MW, et al. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Research. 67: 4665-70. PMID 17510392 DOI: 10.1158/0008-5472.Can-07-0217  0.325
2007 Wang M, Vikis HG, Wang Y, Jia D, Wang D, Bierut LJ, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, Fain PR, Schwartz AG, ... ... Anderson MW, et al. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Research. 67: 93-9. PMID 17210687 DOI: 10.1158/0008-5472.Can-06-2723  0.375
2005 Tichelaar JW, Zhang Y, leRiche JC, Biddinger PW, Lam S, Anderson MW. Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies. Bmc Cancer. 5: 155. PMID 16332260 DOI: 10.1186/1471-2407-5-155  0.359
2004 Clark AM, Reynolds SH, Anderson M, Wiest JS. Mutational activation of the MAP3K8 protooncogene in lung cancer. Genes, Chromosomes & Cancer. 41: 99-108. PMID 15287022 DOI: 10.1002/Gcc.20069  0.381
2004 Herzog CR, Bodon N, Pittman B, Maronpot RR, Massey TE, Anderson MW, You M, Devereux TR. Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression. Oncogene. 23: 3033-9. PMID 14755239 DOI: 10.1038/Sj.Onc.1207431  0.324
2003 Li J, Zhang Z, Dai Z, Plass C, Morrison C, Wang Y, Wiest JS, Anderson MW, You M. LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer. Oncogene. 22: 1243-6. PMID 12606951 DOI: 10.1038/Sj.Onc.1206192  0.414
1996 Anderson M, Sladon S, Michels R, Davidson L, Conwell K, Lechner J, Franklin W, Saccomanno G, Wiest J. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma Journal of Cellular Biochemistry. 63: 185-190. DOI: 10.1002/(Sici)1097-4644(1996)25+<185::Aid-Jcb26>3.0.Co;2-M  0.362
1992 You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH, Anderson M. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proceedings of the National Academy of Sciences of the United States of America. 89: 5804-8. PMID 1352876 DOI: 10.1073/Pnas.89.13.5804  0.365
Show low-probability matches.